Heart pump for severe heart failure in both heart chambers
Part of Heart & circulation clinical trials.
This study tests a new type of heart pump (the DuoCor 2) designed to support both the left and right sides of the heart. The pump is implanted during surgery and may help people with very advanced heart failure feel better and live longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- Your heart failure must be very severe (INTERMACS class 1-2) and you need medications to help your heart pump, or your heart is not pumping enough blood.
- You must have trouble with physical activity (like being unable to walk or walking less than 300 meters in 6 minutes) because of your heart.
- You must have signs of right-sided heart failure, such as swollen legs or visible neck veins.
- Your heart function must meet certain low levels on tests (e.g., ejection fraction ≤30% and high pressure in the lungs).
- You must not have certain other conditions like severe liver or kidney disease, recent stroke, or an untreated large aneurysm.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device that helps both sides of the heart pump blood for people with very weak heart function. It may be an option if you have severe heart failure that isn't improving with standard treatments.
This trial tests a new left ventricular assist device (LVAD) for people with advanced heart failure who are not responding to standard treatments and are eligible for a heart transplant. The pump helps the heart circulate blood.
This trial is studying a non-surgical (conservative) treatment approach for people being considered for a left ventricular assist device (LVAD). It may help some patients who are too sick or unable to tolerate standard heart failure medicines, but it will only match people with specific heart function and health-test results.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
This study is testing a heart pump device for people with very advanced heart failure. It's for patients who are very sick and haven't improved with standard treatments. The study will see if this pump is safe and effective.
This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.
Hear when a new Advanced Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.